• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在抗体样分子中,有一类单域抗体,能够与 SARS-CoV 病毒的核衣壳蛋白相互作用,其中有一些单域抗体对 SARS-CoV-2 病毒的核衣壳蛋白具有高亲和力。

Among Antibody-Like Molecules, Monobodies, Able to Interact with Nucleocapsid Protein of SARS-CoV Virus, There Are Monobodies with High Affinity to Nucleocapsid Protein of SARS-CoV-2 Virus.

机构信息

Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.

Moscow State University, Moscow, Russia.

出版信息

Dokl Biochem Biophys. 2022 Apr;503(1):90-92. doi: 10.1134/S1607672922020077. Epub 2022 May 10.

DOI:10.1134/S1607672922020077
PMID:35538285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9090304/
Abstract

Seven amino acid sequences of antibody mimetics molecules, monobodies, capable of interacting with the nucleocapsid protein of the SARS-CoV virus, were taken from the literature. Nucleotide sequences of monobody genes were obtained by gene synthesis, which were expressed in E. coli and isolated using Ni-NTA chromatography. It was shown by thermophoresis that three of the seven selected antibody-like molecules can interact with high affinity (dissociation constant of tens of nM) with the nucleocapsid protein of the SARS-CoV-2 virus. For the remaining four monobodies, only low affinity binding with a dissociation constant of several μM was found.

摘要

从文献中选取了 7 种能够与 SARS-CoV 病毒核衣壳蛋白相互作用的抗体模拟分子(单域抗体)的 7 个氨基酸序列。通过基因合成获得了单域抗体基因的核苷酸序列,在大肠杆菌中表达并通过 Ni-NTA 层析法进行分离。通过热迁移实验表明,在这 7 种选择的抗体样分子中,有 3 种能够与 SARS-CoV-2 病毒的核衣壳蛋白以高亲和力(解离常数为几十 nM)相互作用。对于其余的 4 种单域抗体,仅发现与解离常数为几个 μM 的低亲和力结合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/115b/9090304/8e1148ff7b60/10628_2022_7300_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/115b/9090304/8e1148ff7b60/10628_2022_7300_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/115b/9090304/8e1148ff7b60/10628_2022_7300_Fig1_HTML.jpg

相似文献

1
Among Antibody-Like Molecules, Monobodies, Able to Interact with Nucleocapsid Protein of SARS-CoV Virus, There Are Monobodies with High Affinity to Nucleocapsid Protein of SARS-CoV-2 Virus.在抗体样分子中,有一类单域抗体,能够与 SARS-CoV 病毒的核衣壳蛋白相互作用,其中有一些单域抗体对 SARS-CoV-2 病毒的核衣壳蛋白具有高亲和力。
Dokl Biochem Biophys. 2022 Apr;503(1):90-92. doi: 10.1134/S1607672922020077. Epub 2022 May 10.
2
Delivery of Antibody-Like Molecules, Monobodies, Capable of Binding with SARS-CoV-2 Virus Nucleocapsid Protein, into Target Cells.将能够结合 SARS-CoV-2 病毒核衣壳蛋白的抗体样分子、单域抗体递送至靶细胞。
Dokl Biochem Biophys. 2022 Oct;506(1):220-222. doi: 10.1134/S1607672922050088. Epub 2022 Oct 27.
3
Modular Nanotransporters Capable of Binding to SARS-CoV-2 Virus Nucleocapsid Protein in Target Cells.能够与靶细胞中 SARS-CoV-2 病毒核衣壳蛋白结合的模块化纳米转运体。
Dokl Biochem Biophys. 2023 Jun;510(1):87-90. doi: 10.1134/S1607672922600233. Epub 2023 Aug 15.
4
Monobodies with potent neutralizing activity against SARS-CoV-2 Delta and other variants of concern.针对 SARS-CoV-2 Delta 及其他关切变异株具有强大中和活性的单域抗体。
Life Sci Alliance. 2022 Mar 7;5(6). doi: 10.26508/lsa.202101322. Print 2022 Jun.
5
A Universal Fluorescent Immunochromatography Assay Based on Quantum Dot Nanoparticles for the Rapid Detection of Specific Antibodies against SARS-CoV-2 Nucleocapsid Protein.基于量子点纳米粒子的通用荧光免疫层析法快速检测 SARS-CoV-2 核衣壳蛋白特异性抗体。
Int J Mol Sci. 2022 Jun 2;23(11):6225. doi: 10.3390/ijms23116225.
6
Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.单次免疫表达刺突蛋白和核衣壳蛋白的重组 ACAM2000 痘苗病毒可保护仓鼠免受 SARS-CoV-2 引起的临床疾病。
J Virol. 2022 May 11;96(9):e0038922. doi: 10.1128/jvi.00389-22. Epub 2022 Apr 12.
7
Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody.开发一种针对 SARS-CoV-2 核衣壳的单克隆抗体。
Virology. 2021 Jun;558:28-37. doi: 10.1016/j.virol.2021.01.003. Epub 2021 Feb 1.
8
Screening and identification of B cell epitope of the nucleocapsid protein in SARS-CoV-2 using the monoclonal antibodies.利用单克隆抗体对 SARS-CoV-2 的核衣壳蛋白进行 B 细胞表位的筛选和鉴定。
Appl Microbiol Biotechnol. 2022 Feb;106(3):1151-1164. doi: 10.1007/s00253-022-11769-6. Epub 2022 Jan 17.
9
Rapid Biosensor of SARS-CoV-2 Using Specific Monoclonal Antibodies Recognizing Conserved Nucleocapsid Protein Epitopes.使用识别保守核衣壳蛋白表位的特异性单克隆抗体的新型冠状病毒快速生物传感器
Viruses. 2022 Jan 27;14(2):255. doi: 10.3390/v14020255.
10
Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies.轻度 SARS-CoV-2 感染与再感染无关,并提供持久的刺突、核衣壳和病毒中和抗体。
Microbiol Spectr. 2021 Oct 31;9(2):e0008721. doi: 10.1128/Spectrum.00087-21. Epub 2021 Sep 1.

引用本文的文献

1
Intracellular Degradation of SARS-CoV-2 N-Protein Caused by Modular Nanotransporters Containing Anti-N-Protein Monobody and a Sequence That Recruits the Keap1 E3 Ligase.由包含抗N蛋白单克隆抗体和招募Keap1 E3连接酶序列的模块化纳米转运体引起的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)N蛋白的细胞内降解
Pharmaceutics. 2023 Dec 19;16(1):4. doi: 10.3390/pharmaceutics16010004.
2
Delivery of Antibody-Like Molecules, Monobodies, Capable of Binding with SARS-CoV-2 Virus Nucleocapsid Protein, into Target Cells.将能够结合 SARS-CoV-2 病毒核衣壳蛋白的抗体样分子、单域抗体递送至靶细胞。
Dokl Biochem Biophys. 2022 Oct;506(1):220-222. doi: 10.1134/S1607672922050088. Epub 2022 Oct 27.

本文引用的文献

1
Expression and purification of recombinant SARS-CoV-2 nucleocapsid protein in inclusion bodies and its application in serological detection.在包涵体中表达和纯化重组 SARS-CoV-2 核衣壳蛋白及其在血清学检测中的应用。
Protein Expr Purif. 2021 Oct;186:105908. doi: 10.1016/j.pep.2021.105908. Epub 2021 May 26.
2
Drug targets for corona virus: A systematic review.冠状病毒的药物靶点:系统评价。
Indian J Pharmacol. 2020 Jan-Feb;52(1):56-65. doi: 10.4103/ijp.IJP_115_20. Epub 2020 Mar 11.
3
Molecular basis of COVID-19 relationships in different species: a one health perspective.
COVID-19 在不同物种间关系的分子基础:一种大健康视角。
Microbes Infect. 2020 May-Jun;22(4-5):218-220. doi: 10.1016/j.micinf.2020.03.002. Epub 2020 Mar 17.
4
Engineered Protein Scaffolds as Next-Generation Therapeutics.工程化蛋白质支架作为下一代治疗药物。
Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:391-415. doi: 10.1146/annurev-pharmtox-010818-021118.
5
Approved Antiviral Drugs over the Past 50 Years.过去50年中获批的抗病毒药物。
Clin Microbiol Rev. 2016 Jul;29(3):695-747. doi: 10.1128/CMR.00102-15.
6
Protein-binding assays in biological liquids using microscale thermophoresis.利用微量热泳动技术在生物液体中进行蛋白质结合分析。
Nat Commun. 2010 Oct 19;1:100. doi: 10.1038/ncomms1093.
7
mRNA display design of fibronectin-based intrabodies that detect and inhibit severe acute respiratory syndrome coronavirus nucleocapsid protein.基于纤连蛋白的细胞内抗体的mRNA展示设计,该抗体可检测并抑制严重急性呼吸综合征冠状病毒核衣壳蛋白。
J Biol Chem. 2009 Jun 26;284(26):17512-20. doi: 10.1074/jbc.M901547200. Epub 2009 Apr 13.
8
The SARS-CoV nucleocapsid protein: a protein with multifarious activities.严重急性呼吸综合征冠状病毒核衣壳蛋白:一种具有多种活性的蛋白质。
Infect Genet Evol. 2008 Jul;8(4):397-405. doi: 10.1016/j.meegid.2007.07.004. Epub 2007 Jul 20.